August 23, 2018
Rose
How to fit these therapies, that are innovative yet extremely expensive, into Medicare's payment model leaves advisers more confused than anything. In other pharmaceutical news, a curtain is pulled back on the drug development process and scientists look to create a new class of drugs to treat malaria.
from Kaiser Health News https://ift.tt/2LnphzT
August 23, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Pandemic-Fueled Alcohol Abuse Creates Wave of Hospitalizations for Liver Disease- La afirmación de Scalise de que los indocumentados tienen prioridad para vacunarse no tiene sentido
- Farmworker Camps to Urban Tent Cities: Tailoring Vaccine Info to Where It’s Most Needed
- Vaccine Hesitancy vs. Vaccine Refusal: Nursing Home Staffers Say There’s a Difference
- As Pandemic Surged, Contact Tracing Struggled; Biden Looks to Boost It
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment